Atlas: Epilepsy Care in the WorldEpilepsy is one of the most common serious disorders of the brain, affecting about 50 million people worldwide. Epilepsy accounts for 1 per cent of the global burden of disease; 80 per cent of the burden of epilepsy is in the developing world, where in some areas 80-90 per cent of people with epilepsy receive no treatment at all. The Epilepsy Atlas provides an illustrative presentation of data and information on the current status of epilepsy services and care available from 160 countries, areas or territories covering 97.5 per cent of the world population. The information is primarily gathered from key persons in the area of epilepsy care in each country identified by International Bureau for Epilepsy and the International League against Epilepsy, and, in some cases, by WHO regional offices. |
Common terms and phrases
000 population aetiology of epilepsy Americas South-East Asia antiepileptic drugs beds for epilepsy brain burden of epilepsy Campaign Against Epilepsy carbamazepine clinical coun developing countries diagnosis different income groups disease disorder electroencephalography epidemiological Epilepsy Atlas epilepsy services epilepsy specialists epilepsy surgery epilepsy syndromes epileptic EUREPA Europe Eastern Mediterranean field of epilepsy Global Campaign groups of countries health professionals health-care high-income countries Higher middle High hippocampal sclerosis ILAE international dollars International League interquartile range involved in epilepsy involved predominantly lepsy low-income countries compared Lower middle Higher median number middle Higher middle neurocysticercosis neurological nurses neurologists neurosurgeons organizations of epilepsy patients with epilepsy phenobarbital phenytoin predominantly in epilepsy providing epilepsy regions rehabilitation resources for epilepsy responding countries Salient findings seizure types seizures social South-East Asia Europe stigma temporal lobe epilepsy tion total number training in epileptology treatment gap valproic acid World Health Organization